| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0B | $3.0B | $3.3B | $3.3B | $2.7B | $0.6B | $0.6B | $0.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.0B | $0.1B | $0.2B | $0.3B | $0.3B | $0.1B | $0.1B | $0.1B |
| Net Income | $-0.0B | $0.0B | $0.1B | $0.2B | $0.3B | $0.1B | $0.0B | $0.1B |
| EPS (Basic) | $-0.24 | $0.55 | $1.77 | $3.76 | $3.84 | $0.88 | $0.70 | $0.77 |
| EPS (Diluted) | $-0.24 | $0.55 | $1.76 | $3.74 | $3.82 | $0.88 | $0.70 | $0.77 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.9B | $3.1B | $3.2B | $3.1B | $2.6B | $2.2B | $2.1B | $2.1B |
| Current Assets | $0.6B | $0.5B | $0.6B | $0.8B | $0.6B | $0.5B | $0.5B | $0.5B |
| Cash & Equivalents | $0.1B | $0.0B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $1.5B | $1.6B | $1.6B | $1.6B | $1.2B | — | — | — |
| Current Liabilities | $0.3B | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B |
| Stockholders' Equity | $1.4B | $1.5B | $1.5B | $1.4B | $1.3B | $1.2B | $1.1B | $1.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.3B | $0.5B | $0.4B | $0.3B | $0.4B | $0.4B | $0.4B |
| Investing Cash Flow | $-0.2B | $-0.2B | $-0.4B | $-0.5B | $-0.4B | $-0.3B | $-0.3B | $-0.3B |
| Capital Expenditures | $0.3B | $0.4B | $0.6B | $0.5B | $0.4B | $0.4B | $0.4B | $0.5B |
| Financing Cash Flow | $0.0B | $-0.1B | $-0.1B | $0.1B | $0.1B | $-0.2B | $-0.2B | $-0.1B |